{'en': 'Cessation of marketing of several insulins', 'es': 'Cese de comercialización de varias insulinas'} Image

Cessation of marketing of several insulins

  
SilviaGRZ
10/15/2024 11:36 a.m.

I leave this info that have happened to me:

Link HTI79IU_AEM_FFRC_GGZXAMUR80PCJ0PWQ#

Silvia (España)
Fiaps + Toujeo.
Díabética desde los 4 años. Ahora tengo 38.
Hbg cambiante.

  
Ruthbia
10/15/2024 3:04 p.m.

I have never had problems with Novorapid Flexpen ... do they say since 2023?I don't know.

Lada enero 2015.
Uso Toujeo y Novorapid.

  
meginer
10/15/2024 6:53 p.m.

ruthbia said:
I have never had problems with Novorapid flexpen ... do they say since 2023?I don't know.

At work today has also reached me.Then I will read it.

No signature configured, add it on your user's profile.
  
diabestico
10/15/2024 7:03 p.m.

meginer said:
ruthbia said:
I have never had problems with Novorapid flexpen ... do they say since 2023?I don't know.

At work today has also reached me.Then I will read it.

Pass it please, if it is something important

No signature configured, add it on your user's profile.
  
meginer
10/16/2024 3:01 p.m.

Basically it is the same as Ruthbia has put.Above all Actrapid Innolet (which is barely used), Novorapid Flexpen, Fiasp, Levemir Innolet.
I imagine that they will solve it and that the lack of stock will not be in all pharmacies at the same time ...
A priori does not affect me at the moment PQ use Humalog and Tresiba but you never know.A roll to have to be aware of this.

No signature configured, add it on your user's profile.
  
JuanSolo
10/16/2024 3:42 p.m.

This is more a form of laboratory pressure to raise prices.
If I have novo, I have an insulin Humalog prescribed, so they are going to lose more.

No signature configured, add it on your user's profile.
  
Ruthbia
10/16/2024 5:44 p.m.

If we fail, then nothing to the header and that it prescribes another.
We will have to try whatever it is, although we have never used it, never put on is not the solution.

Lada enero 2015.
Uso Toujeo y Novorapid.

Join the Discussion!

To participate in this thread, please register or log in.